Recro Pharma Story

Under 67% of Recro Pharma's investor base is looking to short. The analysis of current outlook of investing in Recro Pharma suggests that many traders are alarmed regarding Recro Pharma's prospects. Recro Pharma's investor sentiment overview provides quick insight into current market opportunities from investing in Recro Pharma. The current market sentiment, together with Recro Pharma's historical and current headlines, can help investors time the market. In addition, many technical investors use Recro Pharma stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Recro Pharma stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Recro daily returns and investor perception about the current price of Recro Pharma as well as its diversification or hedging effects on your existing portfolios.
  

Requested story not found. it has been either deleted or moved. View all stories for Recro Pharma.

Recro Pharma Latest Timeline

Recro Pharma is listed for 0.00. About 65.0% of the company shares are owned by institutional investors. The book value of Recro Pharma was at this time reported as 0.95. The company recorded a loss per share of 0.57. Recro Pharma had not issued any dividends in recent years. The entity had a split on the 22nd of November 2019.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey.
You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.

Other Consideration for investing in Recro Stock

If you are still planning to invest in Recro Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Recro Pharma's history and understand the potential risks before investing.
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Fundamental Analysis
View fundamental data based on most recent published financial statements
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.